Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3951
Prudential
PUK
$31B
| $228K | ﹤0.01% |
9,210
-12,017
| -57% | -$333K |
2026 Q2
1 quarter
|
|
3952
CALL
VanEck Uranium + Nuclear Energy ETF
NLR
$2.98B
| $228K | ﹤0.01% |
+2,200
| New | +$249K |
2026 Q3
0 quarters
|
|
3953
Chain Bridge Bancorp
CBNA
$344M
| $227K | ﹤0.01% |
+4,923
| New | +$224K |
2026 Q3
0 quarters
|
|
3954
iShares Russell Mid-Cap Value ETF
IWS
$15B
| $226K | ﹤0.01% |
+1,409
| New | +$236K |
2026 Q3
0 quarters
|
|
3955
Simply Good Foods
SMPL
$1.1B
| $226K | ﹤0.01% |
+23,805
| New | +$262K |
2026 Q3
0 quarters
|
|
3956
IAMGOLD
IAG
$9.7B
| $226K | ﹤0.01% |
12,264
-95,644
| -89% | -$1.71M |
2026 Q1
2 quarters
|
|
3957
STRATTEC Security
STRT
$251M
| $225K | ﹤0.01% |
+3,458
| New | +$269K |
2026 Q3
0 quarters
|
|
3958
Enterprise Products Partners
EPD
$80.7B
| $224K | ﹤0.01% |
6,300
| – | – |
2026 Q2
1 quarter
|
|
3959
Mesa Laboratories
MLAB
$760M
| $224K | ﹤0.01% |
+1,726
| New | +$196K |
2026 Q3
0 quarters
|
|
3960
CALL
Ball Corp
BALL
$16.9B
| $224K | ﹤0.01% |
+4,000
| New | +$248K |
2026 Q3
0 quarters
|
|
3961
PUT
Antero Resources
AR
$11.9B
| $224K | ﹤0.01% |
+6,700
| New | +$242K |
2026 Q3
0 quarters
|
|
3962
B&G Foods
BGS
$272M
| $223K | ﹤0.01% |
77,752
+4,762
| +7% | +$16.5K |
2026 Q1
2 quarters
|
|
3963
CALL
Annaly Capital Management
NLY
$13.8B
| $223K | ﹤0.01% |
+11,800
| New | +$265K |
2026 Q3
0 quarters
|
|
3964
CALL
MSC Industrial Direct
MSM
$6.67B
| $223K | ﹤0.01% |
+1,800
| New | +$220K |
2026 Q3
0 quarters
|
|
3965
Agenus
AGEN
$311M
| $223K | ﹤0.01% |
+22,425
| New | +$155K |
2026 Q3
0 quarters
|
|
3966
Codexis
CDXS
$105M
| $222K | ﹤0.01% |
+160,028
| New | +$271K |
2026 Q3
0 quarters
|
|
3967
Anika Therapeutics
ANIK
$185M
| $222K | ﹤0.01% |
11,304
-7,447
| -40% | -$143K |
2026 Q2
1 quarter
|
|
3968
Sagimet Biosciences
SGMT
$775M
| $222K | ﹤0.01% |
+22,441
| New | +$206K |
2026 Q3
0 quarters
|
|
3969
LendingTree
TREE
$496M
| $222K | ﹤0.01% |
+9,073
| New | +$304K |
2026 Q3
0 quarters
|
|
3970
PUT
Etsy
ETSY
$7.61B
| $222K | ﹤0.01% |
+3,100
| New | +$245K |
2026 Q3
0 quarters
|
|
3971
First Industrial Realty Trust
FR
$7.32B
| $221K | ﹤0.01% |
3,715
-92,201
| -96% | -$5.85M |
2026 Q1
2 quarters
|
|
3972
Advantage Solutions
ADV
$401M
| $220K | ﹤0.01% |
8,480
-2,065
| -20% | -$72K |
2025 Q1
6 quarters
|
|
3973
Northwest Bancshares
NWBI
$2.22B
| $220K | ﹤0.01% |
+14,826
| New | +$228K |
2026 Q3
0 quarters
|
|
3974
PUT
KE Holdings
BEKE
$19.3B
| $219K | ﹤0.01% |
13,000
-1,000
| -7% | -$16.8K |
2022 Q3
16 quarters
|
|
3975
Barings BDC
BBDC
$900M
| $219K | ﹤0.01% |
+25,394
| New | +$224K |
2026 Q3
0 quarters
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.